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Summary There are many pressures to improve the standard of care delivered to cancer patients, including the reforms subsequent to the
Calman-Hine report. The establishment of standards is a prerequisite for audit, benchmarking and certification of cancer centres and units.
Randomized trials of head and neck cancer are uncommon, and other forms of evidence often conflicting. In the south and west of England,
a multidisciplinary expert panel consensus method has been applied to the development of standards. A panel representative of specialties
involved in the process of care at all three levels, plus social medicine and lay members, was constructed. A model for the process of care
was developed consisting of activity areas. For each activity, a near exhaustive list of tasks and standards was established. A three-iteration
method with statistical group response was then used to refine the standards. The same method was also applied to the production of a
minimum data set for registration, recording and audit. The resulting standards will be regularly reviewed. We have developed a model of the
care process, and an expert panel methodology that is applicable to a wide range of problems in clinical oncology.
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Head and neck cancer makes up about 6% of new cancers in the
south and west of England (South and West Cancer Intelligence
Unit data) and is an increasing problem in most parts of the world
(Gile et al, 1994; Tobias, 1994). It is a heterogeneous disease, with
its behaviour being histology and site dependent (Maran et al,
1993). The functional and psychological effects of head and neck
cancer are as profound as those seen in any other form of malig-
nancy (Lansky et al, 1988). Yet, despite advances in radiotherapy
and surgery, including increased interdisciplinary co-operation, 5-
year mortality rates have not improved for 30 years (Stell 1992;
Gile et al, 1994). These problems are not unique to head and neck
cancer, however, and the study of how patients progress from first
symptoms to eventual outcomes represents an important model for
the study of care processes in clinical oncology. The results of
experience and experiment using this model should be transferable
to other cancer sites.
A standard is a 'quality or specification by which something
may be tested or measured' (Oxford English Dictionary). It is 'a
precise and authoritative statement of the criteria necessary to
ensure that a process is fit for the purpose for which it is intended'.
To effectively facilitate improvements in care, standards have to
meet some important criteria (Dale and Oakland, 1991). They
must be practical, prepared in response to a recognized need,
evidence based, regularly reviewed and prepared at a broad level.
There is good evidence for the need for standards in head and
neck cancer care. Studies have indicated considerable disparity in
treatments for patients with head and neck cancer (Maher and
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Jefferis, 1990), and that management decisions depend on the
background of the clinician responsible for care (O'Sullivan et al,
1994) and the geographical location of the patient (O'Sullivan et
al, 1994; Bradley, 1989). In paediatric oncology, in which stan-
dards have been in place for some time, survival rates have
increased (Stiller, 1988).
The report of the Expert Advisory Group on Cancer, the
'Calman-Hine Report' (Calman and Hine, 1995), suggests guide-
lines for early and urgent referral as well as improvements in feed-
back to GPs. Site-specific statements ofintent on these issues were
supplied by all hospitals as part of the application process for
provisional cancer centre or unit status. Now that cancer centres
and units have been nominated, there is the potential for a prolifer-
ation of 'guidelines' by the many hospitals involved. This makes
the need for valid regional standards an urgent one.
As a result of the implementation of this report, it has been
made a prerequisite of the conferment of cancer centre status that
standards exist and be used. A further requirement is the reinforce-
ment of health authority and professional body requirements for
audit, and effective audit also requires established standards.
The financial cost oftreating patients with head and neck cancer
(Million, 1994) is high. In the absence of clear standards,
providers of care at all levels may well adopt cheaper options for
care rather than those that are likely to provide better outcomes for
patients. For all these reasons, therefore, there is a very clear need
to be able to measure the standard of head and neck care at all
levels, from primary care upwards.
The requirement of an evidence base for standards presents
particular difficulties in the current setting. In common with other
malignancies ofintermediate incidence, most ofthe evidence base
in head and neck oncology is non-experimental in nature, with
relatively few reported randomized controlled clinical trials of
sufficient study power (Kelly, 1997). There remains considerable
dispute about the correct therapy for many sites and stages of
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disease, such as T carcinoma of the larynx. Poor registration of
cancers has made extrapolation from these data sources difficult.
For example, a recent study of head and neck cancer in the south
west revealed that less than 2% of cases had stage data recorded
(Thorne et al, 1997). These factors present considerable difficul-
ties for those attempting to establish standards and guidelines for
care. Fortunately, despite these problems, the use of qualitative,
consensus methodology may still allow meaningful standards to
be developed based on experience and 'expert opinion' (Jones and
Hunter, 1996). A review of the available consensus methods
suggested that the expert panel, or nominal group, method might
be the most appropriate.
The aims of the current study are to develop a model for the
process of head and neck cancer care, to determine the applica-
bility of a modified expert panel technique in determining stan-
dards for this area ofoncology, to use this technique to obtain a set
of regionally agreed standards for head and neck cancer care and
to establish a minimum data set for head and neck cancer for
recording, audit, research and registration purposes.
METHODS
The method selected for establishing standards for head and neck
cancer care was a modified expert panel (or nominal group)
method. This is a consensus method, originally developed in the
USA, and already has been usefully applied to health service prob-
lems. For example, the derivation of appropriate outcome
measures in orthopaedics (Liang et al, 1991). Like other consensus
methods, this technique allows synthesis of standards when little
and/or contradictory information exists, as is the case for head and
neck cancer.
Assembling the panel
Requirements for assembling the panel were that composition
should be representative of those professionals involved in care of
patients with head and neck cancer, and that each member could, in
some way, be regarded as having expertise in this area (Jones and
Hunter, 1996). In addition, members were also selected to ensure
representation ofthree levels: primary care, district general hospital
and teaching hospital. These approximate to the levels subse-
quently identified by the Calman-Hine Report (Calman and Hine,
1995; Haward, 1995): primary care, cancer 'units' and cancer
'centres'. Composition according to the two methods ofclassifica-
tion is shown in Figure 1. As the discussions included many topics
of general interest with implications for service configurations,
representatives from public health medicine were also included.
Finally, membership was checked and refined to ensure a broad
geographical representation across the south and west. It has been
shown previously that doctors selected in this way express views
that are representative oftheir colleagues (McKee et al, 1991).
Protocol
The process used to determine standards for head and neck cancer
care is shown in Figure 2. At the first meeting, the aims and objec-
tives were outlined and a chairperson was elected. An outline
pathway for the process ofhead and neck cancer was sketched out
by the use of a 'brainstorming' technique, and then activity areas
at various points along the process were allocated to individual
panel members for development.
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Figure 1 Composition of the south and west expert panel for head and
neck cancer by specialty and Calman-Hine level. Pie charts showing the
composition of the expert panel by 'level' of care. (A) pre-Calman-Hine;
(B) post-Calman-Hine
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Figure 2 Modified expert panel method used for preparation of standards
for the process of head and neck cancer care. Flow-chart showing the expert
panel method used for preparation of standards for the process of head and
neck cancer care
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Figure 3 Model of the process of head and neck cancer care developed for
this study in patients presenting for the first time. Each box represents a
discrete activity area
At the following three meetings, panel members presented an
analysis oftheir views on the main points within their activity area,
illustrated with reference to published evidence whenever possible.
Each activity area in turn was discussed and a near exhaustive set
of provisional standards determined (first iteration). The same
process was applied to determination ofa minimum data set.
When all presentations were completed, the standards were
tabulated. These tables were distributed to each panel member.
Panel members were asked to record their views on each standard
in an open-ended manner. They were also asked to grade the
importance of each standard for the process of head and neck
cancer care on a 0-10 linear analogue scale. Replies were collected
and open-ended comments collated. Anonymity of responses was
maintained. The same method was applied to points within a
minimum data set. Linear analogue responses were presented as
summary statistics (median and range).
The results of the anonymous survey were re-presented to the
panel, and further discussion and refinement completed (second
iteration). Those points scoring low median marks were addressed
in turn, allowing the reduction of the original standards list by 11
points, and the original data set by 5 points.
At this stage, the results were again collated and recirculated to
check for inconsistencies (third iteration) before finalizing. One
inconsistency was identified and rectified at this stage.
RESULTS
The first phase of the study required the development of a model
for the process of head and neck cancer care. This is shown in
Figure 3. Each box represents a separate activity area for standards,
each of which is divided into a series of tasks. The hierarchical
model for this breakdown is shown in Figure 4. An example ofthe
standards for a particular activity area is represented in Table 1.
The intervals between each activity were the subject of a separate
series ofminimum standards, shown in Table 2. The minimum data
set determined by the expert panel method are shown in Table 3.
Standard,
e.g. communicate to GP/GDP within 5 days
Figure 4 Diagram demonstrating the hierarchical structure adopted for defining standards
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Table 1 An exert from the standards for the process of head and neck cancer care developed by the present study
Activity Task Standard
Diagnosis and staging Responsibility 95% should be by a head and neck specialist
TNM staging in 100%
Examination 50% of oral cavity carcinoma
under anaesthesia (EUA) 90% of other tumours
Radiology 90% of radiological investigations should be
performed and reported before treatment
planning
CT/MRI 90% T3/T4 tumours at all sites and
100% of nose/sinus/ear tumours
CXR 100% of all head and neck cancers
OPG 100% oral and oropharyngeal tumours
Biopsy 100% of new cases require a histological
diagnosis of cancer prior to treatment planning
Fine-needle Cytological examination of fine-needle aspirates
aspiration should be available in 95% of units and centres
biopsy 80% of neck masses
80% of parotids
For definitions of process, activity and tasks see Figure 4.
Table 2 Maximum acceptable intervals between activities in the process of care
Time between activities Standard
First symptoms to GP/GDP presentation
GP/GDP to first outpatients
Clinic note to GP/GDP
Fine-needle aspiration biopsy/biopsy arrival at pathology department
Time for frozen section result
Biopsy to report issue
General clinic to specialist H&N OPD
H and N OPD to EUA/panendoscopy/dental/prosthetic
H and N OPD to radiotherapy, chemotherapy (curative intent)
H and N OPD to radiotherapy, chemotherapy (palliative intent)
H&N OPD to ablative surgery
Within radiotherapy or chemotherapy course
Primary treatment to rehabilitation (speech, swallowing, needs assessment)
Treatment to first follow-up clinic
1 month
10 working days
5 working days
no wait
30 min for one, 45 min for multiple
5 working days
10 working days
5 working days
10 working days to planning for RTX or start CTX
5 working days to planning
10 working days
As planned and documented
No delay
1 month
GP, general practitioner; GDP, general dental practitioner; H and N, head and neck; OPD, outpatient department; EUA, examination under
anaesthetic.
DISCUSSION
The determination of standards is essential for site-specific areas
of oncology. Here, a modified expert panel method has been
applied to the process of head and neck cancer care in the south
and west of England. The result has been the distillation of stan-
dards for the process of care, for times between activities and a
minimum data set for recording, registration and audit purposes.
There have been previous attempts to assemble quality assur-
ance documents for head and neck cancer in the UK (Glaholm et
al, 1995; Rhys-Evans, 1995). These documents represent guide-
lines for care, rather than true standards, and have not used formal
consensus methods in their construction. Standards including
defined (preferably numerical) targets to be reached in order to be
associated with the minimum level consistent with a high standard
of care are uncommon. The current study shows that, given suffi-
cient time and thought, it is possible to use a representative sample
ofexperts to produce standards with set targets across a wide range
ofactivity areas within head and neck cancer care.
It is necessary for us to look again at the requirements for stan-
dards, and to examine how well the results of the expert panel
method fulfilled them. The need for standards is clear, as described
above. Whereverpossible, the standards were drawn up with refer-
ence to the evidence base alluded to above, but for the majority of
areas sufficient disagreement existed to make consensus evidence
the only valid option. Nonetheless, it is acknowledged that there
are ongoing trials in this field, the results of which will require
regular review under the current standards (UKCCR, 1991;
Dische, 1995), for standards can only be as good as the evidence
available at the time they were drawn up. It is currently planned to
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Table 3 Minimum data set for head and neck cancer determined by the
present study
Area Point
Patient identifiers Hospital
GP/GDP
Name
Date of birth
Hospital number
Co-morbidity ASA at first combined clinic (ASA, 1987)
QOL at presentation (EORTC, 1995)
QOL at 6/12 follow-up
Pathology
Radiology
Staging
Process
Surgery
Tumour site/subsite (ICD10, 1994)
Is this a recurrence (yes/no)
Clear margins (yes/no)
Number positive nodes
Extracapsular spread (yes/no)
Perineural spread (yes/no)
Perivascular spread (yes/no)
Histological type
CXR, OPG, CT, MRI (whether performed yes/no)
Clinical stage (TNM, AJCC, 1988)
Clinical stage (EUA)
Radiological stage (CT, MRI)
Pathological stage
Dates of each event in disease/treatment
Operation type
Named consultant surgeon (RCS coded)
Reconstruction method
Named reconstructor (RCS coded)
Immediate complications (first 24 hours)
Early complications (less than 30 days)
Late complications (more than 30 days)
Radiotherapy Named consultant radiotherapist and oncologist
Radiotherapy intent: curative/palliative
Radiotherapy type
Dose, fractionation and duration (actual)
Gaps other than weekends (yes/no)
Response of tumour (CR or<CR)
Early complications
Late complications
Chemotherapy Chemotherapy type
Complications
Response of tumour (CR, PR, nil)
Death location
Head and neck cancer given as a cause of death (yes/no)
review the standards every 2 years, unless majorbreakthroughs in
treatment, such as those suggested by work on gene therapy, occur
in the interim. If standards are not so reviewed, they may become
irrelevant or, worse, may actually hinder progress by suggesting
outdated goals.
Standards should be prepared to the broadest level consistent
with meeting the needs ofallparties concerned within a reasonable
time-scale. In the case of a multidisciplinary process, such as head
and neck cancer care, we would argue that the minimum accept-
able level is regional. However, some would argue that if the need
for standards exists, the correct level would be either national or
international (e.g. European). Such standards might be accepted
and used more readily than those produced at a more local level.
Yet, the preparation and, crucially, the long-term maintenance of
meaningful standards, especially if formal consensus methods are
used, is time consuming and potentially costly. Certainly, in the
UK or the EU there is no central funding for standard setting in
oncology. Until such funding exists, meaningful initiatives at a
supra-regional level may remain impractical.
The completion of this study has taken more than 2000 man
hours of expert panel member time. So far, this time has been
given freely by those involved, without any sessional payments or
centrally funded travel costs. If repeated regularly and for all site-
specialist areas, this exercise would have considerable service and
cost implications. As the need for standards is no less compelling
in any other area of oncology, we would argue that there is a need
for both central funding and official recognition of standards
produced in a systematic and representative manner.
The regular revisiting of standards requires considerable disci-
pline on the part of an expert panel. In practice, there is no reason
why the membership of the panel should not change if members
felt they had contributed sufficiently. In fact, such turnover of
membership would form a valuable part of the continuous
improvement process, preserving representativeness as service
configurations change with time.
Standards are, of necessity, provisional. It has been suggested
that the results of consensus methods may represent 'collective
ignorance' just as much as wisdom (Jones and Hunter, 1996). As a
result, it is important to validate them by reference to actual prac-
tice. The standards, although distilled, are still too wide ranging to
be validated by a single audit. However, a prospective audit has
been set up, based on elements of the standards, to examine the
'cancer journey' for patients with head and neck cancer. Other
points will be tested by local audits, and a few by the results of
ongoing randomized clinical trials (UKCCR, 1991; Dische, 1995).
Standards also have to be practical, and the panel noted that part of
this practicality is financial. As the Calman-Hine reforms are
intended to be 'cost neutral', money may prove to be the biggest
limiting factor ofall.
The selection of the panel was made to ensure fair representa-
tion in terms ofgeography, specialty and size of institution. At the
time the panel was originally constituted, trusts in the south and
west were divided into teaching hospitals and district general
hospitals, and equal numbers of members drawn from each.
Subsequently, trusts in the region have been designated as cancer
centres or units in such a way that the balance of the panel may
seem skewed (Figure 1). Nevertheless, we feel that the member-
ship remains representative ofthose currently involved in head and
neck cancer care in the south and west.
In addition to the prerequisites for standards outlined above, the
Department of Health in its 'guidelines for guidelines' has added
the requirement oftaking into account 'patient choices and values'
(NHSME, 1993). To this, we could reasonably add, as do Calman
and Hine (1995), the choices and values of carers. It is easy to see
why previous attempts at quality documents for head and neck
cancer (Glaholm et al, 1995; Rhys-Evans, 1995) avoided this
aspect as the assaying of such choices and values with any degree
ofvalidity requires time- and resource-consuming methods such as
interviews and focus groups (Kitzinger, 1995). As an illustration,
those patient and patient group representatives initially invited
onto the panel felt too inhibited by the process to contribute fully.
Further, the representativeness ofone or two such persons could be
seriously questioned. Therefore, it is an important future phase of
development that these views be sought with particular reference
to the current results, leading to further refinement.
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Another objection to the use of standards in clinical practice is
the perceived potential for 'abuse' by health authorities and trusts
and patient groups, particularly in the area of litigation. However,
we would argue that the adoption of set standards empowers units
and centres to press for greater resources to achieve them, whereas
achievement ofestablished standards provides a powerful defence
against potential litigation. Viewed in these ways, standards are
clearly the clinicians' friend.
The establishment of a minimum data set for a site-specific area
of oncology is an important step that allows standardized
recording for head and neck cancer, and facilitates audit, research
and registration. An agreed minimum data set for site-specific
cancers is also necessary for the establishment of an effective
computerized database. Such databases are a further prerequisite
for the granting of cancer centre or unit status to provider trusts.
We found the expert panel method particularly applicable to this
part ofthe study as the data set is a simple list that is easily refined
by the statistical feedback technique used.
The establishment ofstandards is a crucial early step on the road
to planned, steady improvement in cancer care. We have applied a
modified expert panel consensus technique to the distillation of
standards for care in head and neck cancer. The standards
produced represent a comprehensive tool for internal improvement
and comparative studies, including audit. In addition, we have
produced a minimum data set to assist in the standardization of
recording of cases for audit, research and registration purposes.
Further work is required to validate and refine the standards by
'field-testing', research and the incorporation of patient and carer
views. The standards will be reviewed biannually to maintain rele-
vance. The modified expert panel technique is appropriate for the
distillation of site-specific standards for care in clinical oncology.
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